Covid-19 and the Paradox of Scientific Advice
Bibliographic Data
| ID | 6319247 |
|---|---|
| Authors | Zeynep Pamuk (0000-0003-0057-0495, corresponding author) |
| Year | 2022 |
| Volume | 20 |
| Issue | 2 |
| Pages | 562-576 |
| Publication date | 2022-06-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Perspectives on Politics (JOURNAL) |
| Journal identifiers | ISSN: 1537-5927 • E-ISSN: 1541-0986 |
| Publisher | Cambridge University Press (CUP) (PUBLISHER) |
| DOI | 10.1017/s1537592721001201 |
| OpenAlex | W3175116023 |
| Language | EN |
| Citations received | 21 |
| References cited | 40 |
The scientific advisory committee is a neglected political institution whose importance became clear during the COVID-19 pandemic. What I call “the paradox of scientific advice” consists in that the two basic expectations from scientific advisory committees—neutrality and usefulness—are inherently in tension. To be useful, advisers must help governments set and attain their goals. Judgments about values and ends are necessary for useful advice, as are subjective judgments in the face of uncertainty and disagreement. This puts the committee in a double bind: if it tries to be more useful, it compromises the neutrality that is the source of its authority and legitimacy; if it tries to remain neutral, it sacrifices usefulness. I argue that this dilemma cannot be solved within the committee but that broader democratic scrutiny could mitigate its force. Advisory committees, in turn, should be structured to facilitate this scrutiny
Advice (programming · Advisory committee · Coronavirus disease 2019 (COVID-19 · Democracy · Democratic legitimacy · Dilemma · Epistemology · Face (sociological concept · Institution · Law and economics · Legitimacy · Neutrality · Political science · Politics · Public relations · Scrutiny · Set (abstract data type · Social science · Sociology · Computer Science · Ethics in medical practice · Feminist Epistemology and Gender Studies · Healthcare Systems and Challenges · Law · Medicine · Public Administration
Universities, science, and politics
Between Political Impartiality and Engagement
Covid-19 and science advice on the ‘Grand Stage’
The Applied Epistemology of Official Stories
Machine Advisors
Enhancing Trust in Science
The Role of Expert Networks in Pandemic Governance and Recovery
Between comparison and commensuration
Covid-19 vaccine mandates for healthcare workers and the science advice system in Greece
Diffusion by Leadership
Crisis politics of dehumanisation during Covid-19
Can we do inclusive politics in urgent times
Bespoke science
A (Consequence-Oriented) critique of the argument from inductive risk
Toward a Radical Democratic Theory of Expertise
Muting Science
Information and deliberation in the Covid-19 crisis and in the climate crisis
An Unlikely ‘Traitor’ in the ‘War’ against Covid-19
The devil‐angel shift in times of crisis
More pressing matters
Good governance
The fifth branch
Is a Little Pollution Good for You?
A Tapestry of Values
Science, Policy, and the Value-Free Ideal
Science in Democracy
Epistemic trust and the ethics of science communication
In defence of the value free ideal
Public Misunderstanding of Science? Reframing the Problem of Vaccine Hesitancy
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China
Science as Social Knowledge
Ethics and the Limits of Philosophy
Critical Elitism
The Honest Broker
States of Knowledge
Between Tribalism and Trust
Behind Closed Doors
Inductive risk and the contexts of communication
The Irreducible Complexity of Objectivity
The Scientist Qua Scientist Makes Value Judgments
The Risk of Using Inductive Risk to Challenge the Value-Free Ideal
Science and Decision Making
Using Democratic Values in Science
Statistics, Pragmatics, Induction
The Swine Flu Affair
Mutual transformation and the development of European policy spaces. The case of medicines licensing
Why democracies need science
Boundary-Work and the Demarcation of Science from Non-Science
| Unique citing works | 21 |
|---|---|
| Citations per year | 4,2 |
| Citation span | 2021 - 2026 (6) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 20 |